The human microbiome and benign prostatic hyperplasia: Current understandings and clinical implications.

The research of the human microbiome in the preceding decade has yielded novel perspectives on human health and diseases. Benign prostatic hyperplasia (BPH) is a common disease in middle-aged and elderly males, which negatively affects the life quality. Existing evidence has indicated that the human microbiome, including urinary, intra-prostate, gut, oral and blood microbiome may exert a significant impact on the natural progression of BPH. The dysbiosis of the microbiome may induce inflammation at either a local or systemic level, thereby affecting the BPH. Moreover, metabolic syndrome (MetS) caused by the microbiome can also be involved in the development of BPH. Additionally, alterations in the microbiome composition during the senility process may serve as another cause of the BPH. Here, we summarize the influence of human microbiome on BPH and explore how the microbiome is linked to BPH through inflammation, MetS, and senility. In addition, we propose promising areas of investigation and discuss the implications for advancing therapeutic approaches.

Microbiological research. 2024 Jan 03 [Epub]

Jiaren Li, Youyou Li, Liang Zhou, Cheng Li, Jiahao Liu, Dingwen Liu, Yunlong Fu, Yichuan Wang, Jin Tang, Lei Zhou, Shuo Tan, Long Wang

Department of Urology, The Third Xiangya Hospital, Central South University, Changsha, Hunan 410013, China., Department of Urology, The Third Xiangya Hospital, Central South University, Changsha, Hunan 410013, China. Electronic address: .